TITLE

Treatment of type II diabetes

AUTHOR(S)
Nattrass, Malcolm
PUB. DATE
April 1986
SOURCE
British Medical Journal (Clinical Research Edition);4/19/1986, Vol. 292 Issue 6527, p1033
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the clinical management of type II diabetes. Mechanism of action of sulphonylureas; Shift from long to a short acting drug among older patients; Control of hypoglycemia by administering oral hypoglycemic agents.
ACCESSION #
4839060

 

Related Articles

  • Oral hypoglycemic agents in the treatment of type II diabetes. Tal, Alexander // American Family Physician;11/1/1993, Vol. 48 Issue 6, p1089 

    Discusses sulfonylureas and their use as oral hypoglycemic agents in the treatment of non-insulin-dependent (type II) diabetes. Pharmacologic properties; Comparison of oral sulfonylurea drugs; Mechanism of action; Therapeutic results; Side effects; Drug interactions; Biguanides and other drugs.

  • Intensive blood glucose therapy for type 2 diabetics.  // Modern Medicine;Jan99, Vol. 67 Issue 1, p22 

    Discusses the abstract `Intensive Blood-Glucose Control With Sulphonylureas or Insulin Compared With Conventional Treatment and Risk of Complications in Patients With Type 2 Diabetes' by the United Kingdom Prospective Diabetes Study Group published in the September 12, 1998 issue of `Lancet'...

  • Insulin Therapy for Pre-Hyperglycemic Beta-Cell Endoplasmic Reticulum Crowding. Absood, Afaf; Gandomani, Benjamin; Zaki, Anthony; Nasta, Vlad; Michail, Andrew; Habib, Peter M. W.; Hodish, Israel // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Insulin therapy improves β-cell function in early stages of diabetes by mechanisms that may exceed alleviation of glucotoxicity. In advance type 2 diabetes, hyperglycemia causes β-cell damage and ultimately β-cell loss. At such an advanced stage, therapeutic modalities are often...

  • A Rational Approach to Drug Therapy of Type 2 Diabetes Mellitus. Chehade, J.M.; Mooradian, A.D. // Drugs;Jul2000, Vol. 60 Issue 1, p95 

    Several new pharmacological agents have recently been developed to optimise the management of type 2 (non-insulin-dependent) diabetes mellitus. The aim of this article is to briefly review the various therapeutic agents available for management of patients with type 2 diabetes mellitus and to...

  • Clinical pharmacokinetics: brief reports.  // Drugs & Therapy Perspectives;Apr2006, Vol. 22 Issue 4, p16 

    Advances in treatment for type 2 diabetes mellitus have seen an increase in polypharmacy. A higher incidence of hypoglycaemia may occur when multiple antihyperglycaemic agents are used. Potential interactions between oral glucose-lowering agents and other drugs (e.g. those that are widely...

  • First reports of serious adverse drug reactions in recent weeks.  // Drugs & Therapy Perspectives;Apr2006, Vol. 22 Issue 4, p16 

    Advances in treatment for type 2 diabetes mellitus have seen an increase in polypharmacy. A higher incidence of hypoglycaemia may occur when multiple antihyperglycaemic agents are used. Potential interactions between oral glucose-lowering agents and other drugs (e.g. those that are widely...

  • Effects of drug-drug interactions involving oral antihyperglycaemics are, with the exception of hypoglycaemia, mostly clinically unimportant.  // Drugs & Therapy Perspectives;Apr2006, Vol. 22 Issue 4, p18 

    Advances in treatment for type 2 diabetes mellitus have seen an increase in polypharmacy. A higher incidence of hypoglycaemia may occur when multiple antihyperglycaemic agents are used. Potential interactions between oral glucose-lowering agents and other drugs (e.g. those that are widely...

  • chlorpropamide.  // Royal Society of Medicine: Medicines;2002, p152 

    The article provides information on the drug chlorpropamide. It is a sulphonylurea which is used in diabetic treatment of Type II diabetes mellitus. It works by augmenting what remains of production in the pancreas and its effect lasts longer than that of most similar drugs. Unusually for a...

  • gliclazide.  // Royal Society of Medicine: Medicines;2002, p269 

    This article presents information on the drug gliclazide. Gliclazide is one of the sulphonylurea and is used in diabetic treatment of Type II diabetes. It works by augmenting what remains of production in the pancreas. Administration is oral. It may be chosen for patients with renal impairment...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics